Page 256 - IJB-9-2

International Journal of Bioprinting Coronary and peripheral artery disease. State of the art.

As for the type of materials, smart materials, such PLLA Poly (L-lactic acid)
as SMA and shape-memory polymers, are potential PTA Percutaneous Transluminal
candidates for use in future 3DP manufacturing of medical Angioplasty
devices.
PTCA Percutaneous Transluminal
The incorporation of new materials could significantly Coronary Angioplasty
improve the biocompatibility of the final medical device
with respect to the most common devices available in the PU Polyurethane
market. PVA Polyvinyl alcohol
RPSC-CF Rapid Prototyping Sacrificial
Abbreviations Core-coating Forming
3DP 3D printing SE Self-expanding or self-expandable
BMS Bare Metal Stent SLA Stereolithography
BRS Bioresorbable PBF Powder Bed Fusion (selective laser
CAD Coronary Artery Disease melting)
CDs Cyclodextrins SMA Shape Memory Alloy
CIP Carbonyl iron powder SMC Smooth muscle cells
CNT Carbon Nanotube SNAP S-nitrosation of N-acetyl-d-
CVD Chemical Vapor Deposition penicillamine
DED Directed Energy Deposition SS Stainless-steel
DES Drug eluting stent SWCNT Single-walled carbon nanotubes
DLP Digital Light Processing THF Tetrahydrofuran
EC Endothelial cells TPC Thermoplastic copolyester
FDM Fused Deposition Modeling elastomer
GO Graphene oxide VEGF Vascular endothelial growth factor
GR Graphene VPP Vat Photopolymerization
LDH Layered Double Hydroxides VS Vascular stent
(hydrotalcite-like clay minerals) βCD β-cyclodextrin
MDDS Modified Drug Delivery System
mPDC Metacrylated poly(1,12- Acknowledgments
dodecamethylene citrate) None.
MJT Material Jetting Funding
MWCNT Multi-walled carbon nanotubes
PAD Peripheral Artery Disease This work was funded by the Basque Country
PBF Powder Bed Fusion Government/Eusko Jaurlaritza (Department of Education,
University and Research, Consolidated Groups IT448-
PCL Polycaprolactone 22). Sandra Ruiz-Alonso and Fouad Al-Hakim thank the
PCLA Poly(L-lactide-co-ε-caprolactone) Basque Country Government for the granted fellowships
PDA Polydopamine PRE_2021_2_0153 and PRE_2021_2_0181, respectively.
PEDOT:PSS Poli(3,4-etilendioxitiofeno)- Denis Scaini gratefully acknowledges support from
poli(estireno sulfonato) IKERBASQUE, the Basque Foundation of Science.
PEI Polyethyleneimine Conflict of interest
PGD Poly(glycerol dodecanoate) The authors declare no conflicts of interests.
PGDA Poly(glycerol dodecanoate
acrylate) Author contributions
PLA Polylactic acid Conceptualization: Fernando Lopez-Zarraga, Denis Scaini,
PLGA Poly(lactic-co-glycolic acid) Jose Luis Pedraz.

Volume 9 Issue 2 (2023) 248 https://doi.org/10.18063/ijb.v9i2.664